Tricyclic macrolide antibacterial compounds
    1.
    发明授权
    Tricyclic macrolide antibacterial compounds 有权
    三环大环内酯类抗菌化合物

    公开(公告)号:US06992069B2

    公开(公告)日:2006-01-31

    申请号:US10422401

    申请日:2003-04-24

    IPC分类号: A61K31/70 C07H17/08

    CPC分类号: C07H17/08

    摘要: Antibacterial compounds having formula (I) and salts, prodrugs, and salts of prodrugs thereof, processes for making the compounds and intermediates used in the processes, compositions containing the compounds, and methods for prophylaxis or treatment of bacterial infections using the compounds are disclosed.

    摘要翻译: 公开了具有式(I)的抗菌化合物及其前体药物的前体药物和前体药物,其制备方法中使用的化合物和中间体,含该化合物的组合物,以及使用该化合物预防或治疗细菌感染的方法。

    5,6,7-trisubstituted-4-aminopyrido[2,3-D] pyrimidine compounds
    4.
    发明授权
    5,6,7-trisubstituted-4-aminopyrido[2,3-D] pyrimidine compounds 失效
    5,6,7-三取代-4-氨基吡啶并[2,3-D]嘧啶化合物

    公开(公告)号:US6030969A

    公开(公告)日:2000-02-29

    申请号:US58324

    申请日:1998-04-09

    IPC分类号: C07D471/04 A61K31/505

    CPC分类号: C07D471/04

    摘要: A compound having the formula ##STR1## wherein R.sup.1, R.sup.2, R.sup.3, R.sup.4 and R.sup.5 are defined, a method for inhibiting adenosine kinase by administering a compound thereof, a pharmaceutical composition comprising a therapeutically effective amount of a compound thereof above in combination with a pharmaceutically acceptable carrier, a method of treating cerebral ischemia, epilepsy, pain, nociperception, inflammation and sepsis in a mammal in need of such treatment, comprising administering to the mammal a therapeutically effective amount of a compound thereof, and methods for preparation thereof.

    摘要翻译: 具有下式的化合物其中R 1,R 2,R 3,R 4和R 5的定义是通过给予其化合物抑制腺苷激酶的方法,药物组合物,其包含治疗有效量的上述化合物与药学上可接受的载体 ,在需要这种治疗的哺乳动物中治疗脑缺血,癫痫,疼痛,坏死,炎症和败血症的方法,包括向哺乳动物施用治疗有效量的其化合物及其制备方法。